Abstract

PurposeTo build and evaluate a radiomics-based nomogram that improves the predictive performance of the LVSI in cervical cancer non-invasively before the operation.MethodThis study involved 149 patients who underwent surgery with cervical cancer from February 2017 to October 2019. Radiomics features were extracted from T2 weighted imaging (T2WI). The radiomic features were selected by logistic regression with the least absolute shrinkage and selection operator (LASSO) penalty in the training cohort. Based on the selected features, support vector machine (SVM) algorithm was used to build the radiomics signature on the training cohort. Incorporating radiomics signature and clinical risk factors, the radiomics-based nomogram was developed. The sensitivity, specificity, accuracy, and area under the curve (AUC) and Receiver operating characteristic (ROC) curve were calculated to assess these models.ResultThe radiomics model performed much better than the clinical model in both training (AUCs 0.925 vs. 0.786, accuracies 87.5% vs. 70.5%, sensitivities 83.6% vs. 41.7% and specificities 90.9% vs. 94.7%) and testing (AUCs 0.911 vs. 0.706, accuracies 84.0% vs. 71.3%, sensitivities 81.1% vs. 43.4% and specificities 86.4% vs. 95.0%). The combined model based on the radiomics signature and tumor stage, tumor infiltration depth and tumor pathology yielded the best performance (training cohort, AUC = 0.943, accuracies 89.5%, sensitivities 85.4% and specificities 92.9%; testing cohort, AUC = 0.923, accuracies 84.6%, sensitivities 84.0% and specificities 85.1%).ConclusionRadiomics-based nomogram was a useful tool for predicting LVSI of cervical cancer. This would aid the selection of the optimal therapeutic strategy and clinical decision-making for individuals.

Highlights

  • Cervical cancer is the fourth most frequently diagnosed cancer and the fourth leading cause of cancer death in women in 2018 worldwide [1]

  • A preoperative and noninvasive assessment to predict adverse pathologic factors is of great importance to optimize a treatment plan to lower the incidence of post-treatment morbidity and improve the quality of life

  • Lymph-vascular space invasion (LVSI) has been widely recognized as a risk factor in cervical cancer

Read more

Summary

Introduction

Cervical cancer is the fourth most frequently diagnosed cancer and the fourth leading cause of cancer death in women in 2018 worldwide [1]. Postoperative radiotherapy (PORT) is indicated for patients with adverse pathologic factors by the National Comprehensive Cancer Network (NCCN) and the 2018 International Federation of Gynecology and Obstetrics (FIGO) report [5, 6]. A preoperative and noninvasive assessment to predict adverse pathologic factors is of great importance to optimize a treatment plan to lower the incidence of post-treatment morbidity and improve the quality of life. LVSI has been widely recognized as a risk factor in cervical cancer. Previous studies suggest that the presence of LVSI predicts risk of nodal metastasis which has direct impact on the prognosis of cervical cancer patients [10]. As the important but missing link for patients to select an appropriate treatment, the accurate prediction of LVSI before surgery is urgent in clinical practice

Objectives
Methods
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call